Issue link: https://viewer.e-digitaledition.com/i/449285
options provided by healthcare facilities without this capability, but St. Luke's tech- nological innovations offer an alternative that provides symptom relief and improves long-term outcomes. Judicious Use of Technology In addition to financial support from St. Luke's University Health Network, the Heart and Vascular Program's successful incorporation of sophisticated technology is made possible by the department's emphasis on multispecialty collaboration. Cardiologists, cardiac surgeons, interventional radiologists, electrophysiologists, vascular surgeons and critical care specialists play vital roles in constructing treatment plans. "We focus on providing the most current treatments and crafting personalized treat- ment plans for each patient," Dr. Olenchock says. "We accomplish this because multiple specialists bring their experience and expertise to interdisciplinary meetings where we discuss potential treatments. This cross-pollination of specialists reflects the unique culture of St. Luke's." Because St. Luke's physicians have a vast armamentarium from which to choose the most effective treatment for each patient, multispecialty collaboration is critical to homing in on the optimal therapy. "In addition to obtaining institutional com- mitment to technological advances, you have to be sure the quality exists to effectively use such technologies or procedures, but importantly, you also have to be able to gauge the appro- priateness of each treatment," Dr. Olenchock says. "That's the difference at St. Luke's. The network is committed to providing the tools, and our specialists collaborate to determine the appropriateness of each for use in treatment. This process ensures best outcomes." For more information, visit heart.sluhn.org or call 1-866-STLUKES. ■ Darren M. Traub, DO, showcasing mobile EP technology One of Dr. Traub's patients, who has tachycardia-bradycardia syndrome and takes Flecainide to maintain sinus rhythm, has used this monitor with Dr. Traub to manage his medical regimen. When in regular rhythm, his heart rate (HR) is 50–60 beats per minute, but when in AF, the patient's HR accelerates into the 140s. The patient experienced an AF episode at a conference in another state, and using the AliveCor Heart Monitor, sent electrocar- diographic information to Dr. Traub. He adjusted the medication to return the patient's heart rate to between 80 and 90 beats per minute. When the patient returned from the conference, Dr. Traub used cardiover- sion to return the heart rate to normal sinus rhythm. "Working together remotely, we were able to keep him comfortable and safe for his conference and then restore him back to regular rhythm when he returned home," Dr. Traub says. TAVR St. Luke's provides technologically advanced treatments to aortic stenosis patients who previously had no options. The condition commonly affects older patients, and because of their advanced age, many are too frail to undergo open- heart surgery. Through a collaborative approach at St. Luke's Heart Valve Center, Dr. Olenchock works with Dr. Durkin and other specialists to perform transcatheter aortic valve replacement (TAVR). This procedure enables the team to place an artificial valve in the stenotic aortic valve by threading a catheter through the femoral artery, inflating a balloon that pushes the valve open and placing the artificial valve in the space. St. Luke's is a GE Healthcare Global Show Site, which provides early access to state-of-the-art facilities, such as the GE Discovery IGS 730 Hybrid Operating Room — the second such facility in the world, according to Dr. Olenchock. The hybrid OR combines features of a tradi- tional operating room with the advanced technology of a catheterization labora- tory, making it ideal for TAVR and other minimally invasive procedures. The evaluation process for TAVR begins with echocardiographic confirmation of aortic stenosis. Through comprehensive testing, a multidisciplinary cadre of physicians assesses the potential for TAVR treatment. "Patients should have this procedure performed at an institution that has demonstrated high volumes and success with the procedure," Dr. Olenchock says. "Advanced imaging allows precise sizing, which significantly improves long-term outcomes and prevents valve leakage." Many patients who receive TAVR have exhausted all other treatment A DVA N C ED L E A D E X T R AC TI O N A N D P L AC EM EN T When pacemaker or implantable defibrillator leads fracture or become infected, they must be removed. Electrophysiologists typically perform the extraction, and at many hospitals, cardiac surgeons are on call if leads can't be removed endovascularly. This can delay completion of the procedure. St. Luke's University Health Network has estab- lished a protocol to significantly enhance the safety of lead extraction by including cardiac surgeons on the operating team for nearly every procedure. Performing the extractions in St. Luke's hybrid OR further improves safety, notes Darren M. Traub, DO, Medical Director of Cardiac Electrophysiology at St. Luke's University Health Network. Patients also benefit from this collaborative approach when physicians place leads. Some patients require cardiac resynchronization therapy for left bundle branch blockages, which can exacerbate heart failure symptoms. Pacemakers can resynchronize the septum and lateral heart wall to improve the condition, but this requires the placement of a left ventricular pacing lead. This must be placed around the back of the heart, on the cardiac vein, which isn't always reachable. Dr. Traub collaborates with Matthew M. Puc, MD, general and thoracic surgeon at St. Luke's, to provide epicardial and endocardial approaches to lead placement. If the cardiac vein is unreachable endovascularly, Dr. Puc approaches from outside the vein to place the lead. Traditionally, patients would return days or weeks later if the endovascular approach was impossible, but this protocol spares them a second operation. SPECI A L FE AT UR E 1 2 | Eastern Pennsylvania/NW New Jersey MD NEWS ■ M D N E W S . CO M

